Skip to main content
. Author manuscript; available in PMC: 2024 Oct 3.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2024 Apr 3;33(4):576–585. doi: 10.1158/1055-9965.EPI-23-1014

Table 1.

Baseline (2003–2009) characteristics of Sister Study participants (n=50,201) according to their fibroid and endometriosis status at the end of follow-up (up to September 2020)

Fibroid and Endometriosis Status at End of Follow-up
Baseline Characteristics3 All Participants Neither diagnosis Fibroids Fibroids diagnosed < 35 years Endometriosis Endometriosis diagnosed < 35 years
N = 50,201 N = 26,547 (52.8%) N = 19,9321 (39.7%) N = 4,2301 (8.4%) N = 8,9511 (17.8%) N = 3,9701 (7.9%)
Age at Baseline 56 (9) 55 (9) 56 (9) 56 (9) 56 (9) 54 (8)
Race
 Non-Hispanic White 42,038 (84%) 22,996 (87%) 15,773 (79%) 2,891 (68%) 7,547 (84%) 3,316 (84%)
 Non-Hispanic Black/ African American 4,521 (9.0%) 1,465 (5.5%) 2,886 (14%) 1,050 (25%) 741 (8.3%) 375 (9.4%)
 Hispanic 2,315 (4.6%) 1,366 (5.1%) 779 (3.9%) 171 (4.0%) 381 (4.3%) 152 (3.8%)
 Other 1,327 (2.6%) 720 (2.7%) 494 (2.5%) 118 (2.8%) 282 (3.2%) 127 (3.2%)
Education
 High School 7,683 (15%) 4,284 (16%) 2,781 (14%) 617 (15%) 1,345 (15%) 553 (14%)
 Some College 16,930 (34%) 8,606 (32%) 6,956 (35%) 1,559 (37%) 3,314 (37%) 1,538 (39%)
 Undergraduate Degree 13,556 (27%) 7,418 (28%) 5,208 (26%) 1,035 (24%) 2,223 (25%) 998 (25%)
 Graduate Degree 12,032 (24%) 6,239 (24%) 4,987 (25%) 1,019 (24%) 2,069 (23%) 881 (22%)
Body mass index (BMI) at Baseline (kg/m2)
 <18.5 519 (1.0%) 320 (1.2%) 171 (0.9%) 25 (0.6%) 73 (0.8%) 32 (0.8%)
 18.5–25 19,801 (39%) 11,170 (42%) 7,135 (36%) 1,340 (32%) 3,300 (37%) 1,548 (39%)
 25–30 15,971 (32%) 8,334 (31%) 6,439 (32%) 1,396 (33%) 2,910 (33%) 1,261 (32%)
 >30 13,910 (28%) 6,723 (25%) 6,187 (31%) 1,469 (35%) 2,668 (30%) 1,129 (28%)
Physical Activity Including Work
 <10 hours/week 18,901 (38%) 9,907 (37%) 7,620 (38%) 1,610 (38%) 3,285 (37%) 1,471 (37%)
 10–20 hours/week 20,738 (41%) 11,083 (42%) 8,126 (41%) 1,652 (39%) 3,655 (41%) 1,616 (41%)
 20–30 hours/week 8,403 (17%) 4,406 (17%) 3,345 (17%) 779 (18%) 1,583 (18%) 691 (17%)
 >30 hours/week 2,159 (4.3%) 1,151 (4.3%) 841 (4.2%) 189 (4.5%) 428 (4.8%) 192 (4.8%)
Alcohol
 Non-Drinking 9,538 (19%) 4,939 (19%) 3,885 (19%) 965 (23%) 1,804 (20%) 815 (21%)
 <7 drinks/week 33,874 (67%) 17,831 (67%) 13,509 (68%) 2,807 (66%) 6,019 (67%) 2,688 (68%)
 7+ drinks/week 6,789 (14%) 3,777 (14%) 2,538 (13%) 458 (11%) 1,128 (13%) 467 (12%)
Smoking (pack-years)
 Never 28,338 (56%) 14,910 (56%) 11,417 (57%) 2,383 (56%) 4,905 (55%) 2,170 (55%)
 <15 pack-years 13,687 (27%) 7,173 (27%) 5,478 (27%) 1,106 (26%) 2,502 (28%) 1,087 (27%)
 15–30 pack-years 4,890 (9.7%) 2,635 (9.9%) 1,863 (9.3%) 430 (10%) 927 (10%) 426 (11%)
 >30 pack-years 3,286 (6.5%) 1,829 (6.9%) 1,174 (5.9%) 311 (7.4%) 617 (6.9%) 287 (7.2%)
Parity
 No children 9,079 (18%) 4,374 (16%) 3,828 (19%) 811 (19%) 2,180 (24%) 1,018 (26%)
 1 child 7,261 (14%) 3,539 (13%) 3,059 (15%) 791 (19%) 1,547 (17%) 780 (20%)
 2 children 18,450 (37%) 9,882 (37%) 7,242 (36%) 1,483 (35%) 3,107 (35%) 1,388 (35%)
 3+ children 15,411 (31%) 8,752 (33%) 5,803 (29%) 1,145 (27%) 2,117 (24%) 784 (20%)
Age at First Pregnancy
 Never Pregnant 7,762 (15%) 3,941 (15%) 3,059 (15%) 637 (15%) 1,762 (20%) 851 (21%)
 <20 years old 9,536 (19%) 4,629 (17%) 4,217 (21%) 1,064 (25%) 1,751 (20%) 741 (19%)
 20–24 years old 17,466 (35%) 9,117 (34%) 7,187 (36%) 1,470 (35%) 2,950 (33%) 1,213 (31%)
 25–29 years old 9,349 (19%) 5,300 (20%) 3,425 (17%) 590 (14%) 1,433 (16%) 610 (15%)
 30+ years old 6,088 (12%) 3,560 (13%) 2,044 (10%) 469 (11%) 1,055 (12%) 555 (14%)
Breastfeeding
 Never 21,596 (43%) 10,756 (41%) 9,026 (45%) 2,021 (48%) 4,416 (49%) 1,930 (49%)
 <1 year 16,407 (33%) 8,556 (32%) 6,628 (33%) 1,393 (33%) 2,927 (33%) 1,323 (33%)
 1–2 years 6,503 (13%) 3,768 (14%) 2,343 (12%) 436 (10%) 929 (10%) 415 (10%)
 >2 years 5,695 (11%) 3,467 (13%) 1,935 (9.7%) 380 (9.0%) 679 (7.6%) 302 (7.6%)
Age of Menarche
 <12 years old 10,254 (20%) 4,847 (18%) 4,606 (23%) 1,123 (27%) 2,093 (23%) 965 (24%)
 12–14 years old 28,194 (56%) 15,027 (57%) 11,109 (56%) 2,304 (54%) 4,874 (54%) 2,124 (54%)
 >14 years old 11,753 (23%) 6,673 (25%) 4,217 (21%) 803 (19%) 1,984 (22%) 881 (22%)
Years taking oral contraceptives
 Never 8,015 (16%) 4,399 (17%) 3,113 (16%) 648 (15%) 1,190 (13%) 465 (12%)
 0–2 years 7,948 (16%) 3,916 (15%) 3,415 (17%) 763 (18%) 1,559 (17%) 696 (18%)
 2–10 years 21,556 (43%) 11,291 (43%) 8,604 (43%) 1,901 (45%) 3,959 (44%) 1,882 (47%)
 10+ years 12,682 (25%) 6,941 (26%) 4,800 (24%) 918 (22%) 2,243 (25%) 927 (23%)
Hormone Replacement Therapy
 None 28,056 (56%) 16,404 (62%) 10,044 (50%) 2,038 (48%) 3,832 (43%) 1,728 (44%)
 Estrogen and Progestin 12,388 (25%) 7,016 (26%) 4,442 (22%) 833 (20%) 1,982 (22%) 863 (22%)
 Estrogen Only 9,757 (19%) 3,127 (12%) 5,446 (27%) 1,359 (32%) 3,137 (35%) 1,379 (35%)
Surgery2
 No Surgery 34,241 (68%) 21,940 (83%) 10,482 (53%) 1,765 (42%) 3,716 (42%) 1,685 (42%)
 Hysterectomy Only 6,929 (14%) 2,374 (8.9%) 3,913 (20%) 1,259 (30%) 1,763 (20%) 865 (22%)
 Bilateral Oophorectomy Only 234 (0.5%) 141 (0.5%) 78 (0.4%) 13 (0.3%) 36 (0.4%) 10 (0.3%)
 Both 8,797 (18%) 2,092 (7.9%) 5,459 (27%) 1,193 (28%) 3,436 (38%) 2,092 (7.9%)
1

Those subjects who have both fibroids and endometriosis contribute to the statistics of both the fibroids and endometriosis columns.

2

“Hysterectomy Only” indicates hysterectomy but not bilateral oophorectomy; “bilateral oophorectomy” indicates bilateral oophorectomy with or without hysterectomy; “no surgery” indicates neither hysterectomy nor bilateral oophorectomy. Partial/unilateral oophorectomies would either be classified under “no surgery” or “hysterectomy only”.

3

Characteristics are based on status at baseline, while fibroids and endometriosis refer to status at end of follow-up

Mean (SD) or Count (percentage)

Data represented here is the average of all 30 imputed data sets